PD-Rx Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. PD-Rx Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 33% to $28,715,224. The net income raised on $3,033,984 and profit margin reached 11%. Total operating expenses were $7,027,070.
Profit Margin
| 2015 | 19.38M | 540.54K | 2.79% |
|---|---|---|---|
| 2016 | 21.46M | 507.67K | 2.36% |
| 2018 | 24.96M | 621.16K | 2.49% |
| 2019 | 20.87M | -12.91K | -0.06% |
| 2021 | 21.60M | 1.85M | 8.59% |
| 2022 | 28.71M | 3.03M | 10.57% |
PDRX Income Statement (2014 – 2021)
| 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 28.71M | 21.60M | 20.87M | 24.96M | 21.46M | 19.38M |
Cost of revenue | 17.65M | 14.64M | 13.28M | 16.43M | 13.89M | 11.71M |
Gross profit | 11.06M | 6.95M | 7.58M | 8.53M | 7.56M | 7.67M |
Operating exp. | ||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 92K | 88K | 158K | 162K | 0 | 0 |
Total operating expenses | 7.02M | 6.08M | 7.65M | 7.64M | 6.80M | 6.79M |
Operating income | 4.00M | 876.47K | -65.73K | 890.72K | 763.17K | 880.70K |
Other income (expenses), net | 48.37K | 958.22K | 51.29K | 90.08K | 35.12K | 43.80K |
Income before tax | 4.05M | 1.83M | -14.43K | 980.80K | 798.29K | 924.50K |
Income tax expense | 1.01M | -21.63K | -1.51K | 359.63K | 290.62K | 383.96K |
Net income | 3.03M | 1.85M | -12.91K | 621.16K | 507.67K | 540.54K |
Earnings per share | ||||||
Basic EPS | 1.83 | 1.08 | -0.00 | 0.36 | 0.3 | 0.31 |
Diluted EPS | 1.83 | 1.08 | -0.00 | 0.36 | 0.3 | 0.31 |